CDH17 and neoplasm: CDH17 ‘high-methylation’ cases, showed increased expression of IL12B, IL10, CXCL9 and 10 and CCL2 compared to CDH17 ‘low-methylation’ cases, suggestive of a favourable cytokine/chemokine ‘milieu’ in these tumours.